Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion type Assertion NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_head.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion description "[Among the most sensitive were lines with rearrangements of CRLF2, which is overexpressed in ~ 10% of B-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_provenance.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion evidence source_evidence_literature NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_provenance.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion SIO_000772 22904298 NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_provenance.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion wasDerivedFrom befree-2016 NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_provenance.
- NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_assertion wasGeneratedBy ECO_0000203 NP1006449.RAv2DnEnfEbZnQO9SXhAWkCwJfgoGdMK3nvO-M_EA6pOI130_provenance.